has been cited by the following article(s):
|
[1]
|
Mechanistic insight into nanomedicine for polycystic ovary syndrome
Molecular Biology Reports,
2025
DOI:10.1007/s11033-025-10709-7
|
|
|
|
|
[2]
|
Integrative Approaches to Ovulation Induction in Polycystic Ovary Syndrome: A Narrative Review of Conventional and Complementary Therapies
Biomedicines,
2025
DOI:10.3390/biomedicines13112711
|
|
|
|
|
[3]
|
Combination Letrozole and Clomiphene Citrate or Letrozole Alone for Ovulation Induction in Infertile Women with Polycystic Ovarian Syndrome
Pakistan Journal of Health Sciences,
2025
DOI:10.54393/pjhs.v6i10.3317
|
|
|
|
|
[4]
|
Combined Letrozole and Clomiphene Citrate Versus Letrozole Alone in Ovulation Induction for Polycystic Ovarian Syndrome Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Reproductive Sciences,
2025
DOI:10.1007/s43032-025-01979-4
|
|
|
|
|
[5]
|
Comparison of Letrozole Versus Combination Letrozole and Clomiphene Citrate (CC) for Ovulation Induction in Sub Fertile Women with Polycystic Ovarian Syndrome (PCOS)—An Open Label Randomized Control Trial
Reproductive Sciences,
2024
DOI:10.1007/s43032-024-01743-0
|
|
|
|
|
[6]
|
Assessment of Fertility Outcomes Following Combined Clomiphene and Letrozole Versus Letrozole Therapy for the Treatment of Polycystic Ovarian Syndrome Subfertility
Cureus,
2023
DOI:10.7759/cureus.38886
|
|
|
|